Valeant Pharmaceuticals is a top pharmaceutical company based in Montreal, Quebec, Canada.The company source its origins back to the 1960s, and is the product of numerous mergers and acquisitions – Valeant embodies what can be achieved through critical mass M&A.

Valeant Pharmaceuticals International is a diverse and decentralized pharmaceutical company that is committed to focusing on our key stakeholders while delivering consistently high performance.

Report: Partnering Deals and Alliances with Valeant Pharmaceuticals

Valeant Pharmaceuticals is a top pharmaceutical company based in Montreal, Quebec, Canada.

The company source its origins back to the 1960s, and is the product of numerous mergers and acquisitions – Valeant embodies what can be achieved through critical mass M&A.

Valeant Pharmaceuticals International is a diverse and decentralized pharmaceutical company that is committed to focusing on our key stakeholders while delivering consistently high performance.

Valeant’s values provide the overall direction for the company, and provide it with the tools necessary to rise to any challenge by leveraging our collective hard work and effort along with its unwavering competitive spirit. These values help Valeant set goals based on the organization’s potential and what it hopes it will become.

Valeant has a well-defined business development strategy which is focused on growth driven by merger, acquisition and partnering more

Valeant announced over 55 partnering / licensing deals since 2005, with 11 deals in 2012 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in dermatology, central nervous system, oncology and infective diseases  more

Valeant has also announced 30 M&A deals since 2005, with the lead deals being the acquisition of Medicis, Biovail more

Report: Partnering Deals and Alliances with Valeant Pharmaceuticals

Examples of recent partnering and licensing deals announced by Valeant can be viewed in Current Partnering's Valeant: Partnering activity 2005-2013 review article.

Examples of recent M&A deals announced by Valeant can be viewed in Current Partnering's Valeant: M&A activity 2005-2013 review article. 

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Valeant Pharmaceuticals

Report: Partnering Deals and Alliances with Valeant Pharmaceuticals                                     

Report: Partnering Deals and Alliances with Big Pharma

Available resources for deal coverage for Valeant         

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Valeant company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk